Healthcare Hero: Kara Cossis, Chesapeake Urology April 12, 2023 At Myriad Genetics, our mission is to advance health and well-being for all, and a big component of that is developing reliable, accessible genetic tests for a... Continue Reading
New Guidelines from AUA and ASTRO Support Inclusion of Genomic Testing in Localized Prostate Cancer May 17, 2022 By Thomas Slavin, M.D., chief medical officer, Myriad Genetics According to the American Cancer Society, in 2022 more than 268,000 men in the United S... Continue Reading
Precision Medicine in Prostate Cancer: How Genetic Testing Makes a Difference December 15, 2021 Back when scientists sequenced a human genome for the first time — a years-long project that took billions of dollars — they were in part motivated by the p... Continue Reading
Genetic Testing Can Help Men with Prostate Cancer Receive the Right Treatment September 1, 2018 September is Prostate Cancer Awareness Month. According the American Cancer Society, more than 165,000 men will be diagnosed with prostate cancer this year, and... Continue Reading
Men’s Health Month and Myriad’s Prolaris Test June 12, 2017 June is Men’s Health Month and it’s important to help generate awareness on education for early detection of Men’s health issues, such as prostate cance... Continue Reading
Know the facts about Prostate Cancer (infographic) April 3, 2017 Improving precision matters in prostate cancer Understanding the risk of prostate cancer is very important for men ages 40 and older. Myriad Geneti... Continue Reading
Medicare Covers Prolaris Genetic Test for Low-Risk Prostate Cancer August 13, 2015 On August 13, 2015, Medicare approved coverage of the Prolaris® test for men diagnosed with low-risk and very low-risk prostate cancer. The decision is the cul... Continue Reading
Changing the Lives of Men with Prostate Cancer January 26, 2015 Myriad has led the industry in genetic testing for hereditary breast and ovarian cancer since the launch of BRACAnalysis® in 1996. Since then, we’ve changed ... Continue Reading
The Faces of Prostate Cancer January 26, 2015 All of us at Myriad – from the executives and researchers, to the sales and customer service representatives – work hard because we know that, behind each a... Continue Reading
A Story of Inspiration for Men’s Health Month June 13, 2014 I recently had the honor of meeting Joe (his name has been changed to protect his privacy), a 70-year-old man who was diagnosed with prostate cancer. I aske... Continue Reading
Myriad’s Prolaris Data Spikes Interest in Prognostic Prostate Cancer Testing July 2, 2013 Data recently presented by Myriad Genetics’ prostate cancer prognostic test Prolaris is getting healthcare professionals and patients interested in learning ... Continue Reading
Myriad’s Prolaris(R) Test Predicts Risk of Prostate Cancer Recurrence in Fourth Peer Reviewed Study March 6, 2013 SALT LAKE CITY, March 5, 2013 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that a study published in the Journal of Clinical Oncolo... Continue Reading
Cancer Wellness House Holiday Party December 21, 2012 The holidays are known as a time for giving and Myriad proudly helped bring that giving spirit to the Cancer Wellness House’s annual holiday party. T... Continue Reading
Myriad Presents at the Society for Urologic Oncologists December 3, 2012 This past week Myriad Genetic Laboratories had the opportunity to present 2 posters at the Society for Urologic Oncologists that was held in Bethesda, MD. T... Continue Reading
Myriad Genetics’ Prolaris Test Predicts Biochemical Recurrence in Prostate Cancer Patients Following Radiation Therapy November 28, 2012 SALT LAKE CITY, Nov. 28, 2012 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that a presentation entitled “CCP Score Significantl... Continue Reading